Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edvard Smith

Showing results (151-160 of 178) with videos related to

Pageof 18
Sort By:
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 20, 2025
Advanced peptide nanoparticles enable robust and efficient delivery of gene editors across cell typesOskar Gustafsson, Supriya Krishna, Sophia Borate, et al.
Ebiomedicine|July 15, 2023
Real-world assessment of immunogenicity in immunocompromised individuals following SARS-CoV-2 mRNA vaccination: a one-year follow-up of the prospective clinical trial COVAXIDPuran Chen, Peter Bergman, Ola Blennow, et al.
Molecular Medicine (Cambridge, Mass.)|May 13, 2022
MAIT cell compartment characteristics are associated with the immune response magnitude to the BNT162b2 mRNA anti-SARS-CoV-2 vaccineCaroline Boulouis, Tobias Kammann, Angelica Cuapio, et al.
Nucleic Acids Research|February 25, 2011
PepFect 14, a novel cell-penetrating peptide for oligonucleotide delivery in solution and as solid formulationKariem Ezzat, Samir E L Andaloussi, Eman M Zaghloul, et al.
Ebiomedicine|May 9, 2026
Three-year follow-up of the COVAXID trial: real-world assessment of SARS-CoV-2 mRNA vaccine immunogenicity in immunocompromised individuals highlights increasing roles of hybrid and passive immunityPuran Chen, Peter Bergman, Ola Blennow, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|February 10, 2015
Ultrafiltration with size-exclusion liquid chromatography for high yield isolation of extracellular vesicles preserving intact biophysical and functional propertiesJoel Z Nordin, Yi Lee, Pieter Vader, et al.
Ebiomedicine|October 12, 2024
Real-world assessment of immunogenicity in immunocompromised individuals following SARS-CoV-2 mRNA vaccination: a two-year follow-up of the prospective clinical trial COVAXIDPuran Chen, Peter Bergman, Ola Blennow, et al.
Nucleic Acids Research|February 10, 2016
Next-generation bis-locked nucleic acids with stacking linker and 2'-glycylamino-LNA show enhanced DNA invasion into supercoiled duplexesSylvain Geny, Pedro M D Moreno, Tomasz Krzywkowski, et al.
Stem Cell Reports|April 8, 2016
Wnt/β-Catenin Stimulation and Laminins Support Cardiovascular Cell Progenitor Expansion from Human Fetal Cardiac Mesenchymal Stromal CellsAgneta Månsson-Broberg, Sergey Rodin, Ivana Bulatovic, et al.
Communications Biology|March 2, 2022
Novel endosomolytic compounds enable highly potent delivery of antisense oligonucleotidesJeremy P Bost, Miina Ojansivu, Michael J Munson, et al.
Pageof 18

Showing results (151-160 of 178) with videos related to

Sort By:
Pageof 18
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 20, 2025
Advanced peptide nanoparticles enable robust and efficient delivery of gene editors across cell typesOskar Gustafsson, Supriya Krishna, Sophia Borate, et al.
Ebiomedicine|July 15, 2023
Real-world assessment of immunogenicity in immunocompromised individuals following SARS-CoV-2 mRNA vaccination: a one-year follow-up of the prospective clinical trial COVAXIDPuran Chen, Peter Bergman, Ola Blennow, et al.
Molecular Medicine (Cambridge, Mass.)|May 13, 2022
MAIT cell compartment characteristics are associated with the immune response magnitude to the BNT162b2 mRNA anti-SARS-CoV-2 vaccineCaroline Boulouis, Tobias Kammann, Angelica Cuapio, et al.
Nucleic Acids Research|February 25, 2011
PepFect 14, a novel cell-penetrating peptide for oligonucleotide delivery in solution and as solid formulationKariem Ezzat, Samir E L Andaloussi, Eman M Zaghloul, et al.
Ebiomedicine|May 9, 2026
Three-year follow-up of the COVAXID trial: real-world assessment of SARS-CoV-2 mRNA vaccine immunogenicity in immunocompromised individuals highlights increasing roles of hybrid and passive immunityPuran Chen, Peter Bergman, Ola Blennow, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|February 10, 2015
Ultrafiltration with size-exclusion liquid chromatography for high yield isolation of extracellular vesicles preserving intact biophysical and functional propertiesJoel Z Nordin, Yi Lee, Pieter Vader, et al.
Ebiomedicine|October 12, 2024
Real-world assessment of immunogenicity in immunocompromised individuals following SARS-CoV-2 mRNA vaccination: a two-year follow-up of the prospective clinical trial COVAXIDPuran Chen, Peter Bergman, Ola Blennow, et al.
Nucleic Acids Research|February 10, 2016
Next-generation bis-locked nucleic acids with stacking linker and 2'-glycylamino-LNA show enhanced DNA invasion into supercoiled duplexesSylvain Geny, Pedro M D Moreno, Tomasz Krzywkowski, et al.
Stem Cell Reports|April 8, 2016
Wnt/β-Catenin Stimulation and Laminins Support Cardiovascular Cell Progenitor Expansion from Human Fetal Cardiac Mesenchymal Stromal CellsAgneta Månsson-Broberg, Sergey Rodin, Ivana Bulatovic, et al.
Communications Biology|March 2, 2022
Novel endosomolytic compounds enable highly potent delivery of antisense oligonucleotidesJeremy P Bost, Miina Ojansivu, Michael J Munson, et al.
Pageof 18